OMASP.HEOMASP.HEHEL
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -10.45% | -17.74% | -18.29% | -32.10% | -23.05% |
| Gross Profit Growth | -4.21% | -19.02% | -11.97% | -29.39% | -24.00% |
| EBITDA Growth | -34.28% | -80.54% | +211.75% | -35.93% | -50.82% |
| Operating Income Growth | -36.47% | -87.39% | +313.21% | -32.02% | -46.85% |
| Net Income Growth | -36.53% | -87.77% | +327.77% | -33.07% | -43.70% |
| EPS Growth | -39.33% | -88.33% | +340.00% | -32.73% | -44.44% |
| EPS Diluted Growth | -40.45% | -88.33% | +340.00% | -32.73% | -43.40% |
| Weighted Average Shares Growth | +0.16% | +5.03% | +0.89% | -0.38% | +1.34% |
| Weighted Average Shares Diluted Growth | +2.05% | +4.84% | -2.78% | -0.38% | -0.54% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +1006.36% | +0.00% | +0.00% | -64.04% | -98.00% |
| Free Cash Flow Growth | +1146.29% | +0.00% | +0.00% | -66.35% | -103.91% |
| Receivables Growth | -43.01% | +0.00% | +0.00% | +0.00% | -73.14% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +0.87% | -0.18% | +1.12% | -3.07% | -3.05% |
| Book Value per Share Growth | +6.32% | +5.25% | +9.80% | +8.88% | +5.99% |
| Debt Growth | -8.19% | -6.18% | -9.06% | +3.34% | -0.48% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |